To determine if XRN2 may also contribute to the progression of GBMs, we examined the Pfister, Loeffler, and Hegi glioma gene expression datasets for XRN2 expression, using the R2: Genomic Analysis and Visualization Platform (http://r2.amc.nl, accessed 1 March 2019). Here, XRN2 is linked to central nervous system cancer.